Prof. Dr. Kannan Vishwanatth
-
An Efficient Friendly Process for Synthesis of (2E,6E)-2,6-bis(4-nitrobenzylidene)cyclohexanone a Drug Against Dormant Version of the Mycobacterium Tuberculo-sis H37Ra
219 1Prof.Dr Kannan VishwanatthThe Chinese University of Hong Kong.Emil: drkannanvish@yahoo.com Dr…
Read more -
Prof. Dr. Kannan Vishwanatth floors the V International Economic Forum at Riga, Latvia on The COVID Crisis and Opportunities for Human Well-Being.
464 0Dr. Kannan Vishwanatth of Rupus Global Limited addressed in Plenary…
Read more -
Prof. Dr. Kannan Vishwanatth of Rupus Global Limited joins as the Advisory Board Member of the The School Advisory Council, the HKUST Business School.
43 0Noted Academic Researcher & Rupus Global Limited Managing Director Prof.…
Read more